22 results
Asthma Medications and Mechanism of Action

#Asthma #Medications #Drugs #Pulmonary #Pharmacology #Management #Treatment
Asthma Medications ... and Mechanism of ... #Drugs #Pulmonary ... #Pharmacology #Management ... #Treatment
Summary table of the mechanism of action, side effect and contraindications of commonly used non-steroidal anti-inflammatory
Summary table of ... anti-inflammatory drugs ... #NSAIDS #management ... #comparison #medications ... #treatment
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
response to the drug ... For most indications ... #management #algorithm ... #pharmacology #treatment ... #medications #table
Drug Treatment of Anaphylaxis and Allergic Reactions
First-Line Therapy 
 - Epinephrine 
 - Oxygen 
 -
Drug Treatment of ... Anaphylaxis and ... #Anaphylaxis #Management ... #Pharmacology #Table ... #Medications #Allergy
Summary of meta-analysis of pharmacotherapy trials in BPD
https://www.cochrane.org/CD005652/BEHAV_psychological-therapies-borderline-personality-disorder
Meta-analyses of RCTs were undertaken for the following outcomes:
for the Management ... with ‘treatment ... EBM #Management ... Personality #Disorder #Medications ... Effectiveness #Table
Drugs Used for the Treatment of COVID-19 Infection

** Editor Note (from ophthalmology MD input) - Hydroxychloroquine/chloroquine
Drugs Used for the ... in someone who had ... #Medications #Treatment ... #Pharmacology #Table ... #Management
The 2019 Global Initiative for Asthma (GINA) treatment strategy figure for adults and adolescents, annotated to
Asthma (GINA) treatment ... figure for adults and ... #GINA #Asthma #Management ... #Stepwise #Pulmonary ... #Algorithm #Guidelines
Pharmacologic treatment algorithms by Global Initiative for Chronic Obstructive Lung Disease grade. Highlighted boxes and arrows
Pharmacologic treatment ... algorithms by Global ... indicate preferred treatment ... #Management #Pulmonary ... LAMA #LABA #ICS #Guidelines
Management of interstitial lung disease (ILD)-associated with systemic sclerosis (SSc)

Therapeutic indication: absolute decline in FVC >10%
Management of interstitial ... for extensive and ... systemicsclerosis #SSc #pulmonary ... #indications #management ... #treatment #algorithm
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
exacerbations Drug ... Dosing: 250 mcg tablet ... 2019 COPD GOLD guidelines ... recommendations for the treatment ... the use of this medication